Skip to main content

Phillips Geraint's Form 4 filing

Biolife Solutions Inc (BLFS) · filed Dec 4, 2023

Accession no.
0001628280-23-040674
Filed
Dec 4, 2023
Trade date
Nov 19-Dec 1, 2023
Filing delay
15 daysLate
Rule 10b5-1 plan
Checked

This filing lists 2 non-derivative transactions. Open-market sales total $3.75K. It was filed 15 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Phillips GeraintCIK 0001960665Officer (SVP, Global Operations)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 19, 2023Common StockAGrant or awardAcquired+234––59,890Direct
Dec 1, 2023Common StockSSaleDisposed−303$12.37−$3,748.1159,587Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)